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Tuberculosis (TB) is one of the prevalent causes of death worldwide, with 95% of 
these deaths occurring in developing countries, like India. The causative agent, 
Mycobacterium tuberculosis (MTb) has the tenacious ability to circumvent the host’s 
immune system for its own advantage. Macrophages are one of the phagocytic cells 
that are central to immunity against MTb. These are highly plastic cells dependent on 
the milieu and can showcase M1/M2 polarization. M1 macrophages are bactericidal 
in action, but M2 macrophages are anti-inflammatory in their immune response. 
This computational study is an effort to elucidate the role of miRNAs that influences 
the survival of MTb in the macrophage. To identify the miRNAs against critical 
transcription factors, we selected only conserved hits from TargetScan database. 
Further, validation of these miRNAs was achieved using four databases viz. DIANA-
microT, miRDB, miRanda-mirSVR, and miRNAMap. All miRNAs were identified 
through a conserved seed sequence against the 3′-UTR of transcription factors. This 
bioinformatics study found that miR-27a and miR-27b has a putative binding site at 
3′-UTR of IRF4, and miR-302c against IRF5. miR-155, miR-132, and miR-455-5p are 
predicted microRNAs against suppressor of cytokine signaling transcription factors. 
Several other microRNAs, which have an affinity for critical transcription factors, are 
also predicted in this study. This MTb-associated modulation of microRNAs to modify 
the expression of the target gene(s) plays a critical role in TB pathogenesis. Other 
than M1/M2 plasticity, MTb has the ability to convert macrophage into foam cells that 
are rich in lipids and cholesterol. We have highlighted few microRNAs which overlap 
between M2/foam cell continuums. miR-155, miR-33, miR-27a, and miR-27b plays a 
dual role in deciding macrophage polarity and its conversion to foam cells. This study 
shows a glimpse of microRNAs which can be modulated by MTb not only to prevent 
its elimination but also to promote its survival.
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inTrODUcTiOn
Tuberculosis (TB) is an infectious disease which is caused by 
strains of genus Mycobacteria. The predominant pathogenic 
species that infects humans is Mycobacterium tuberculosis 
(MTb). It is a pulmonary pathogen as its typical life cycle begins 
in lungs of human but can spread to other organs and tissues 
and causes extra-pulmonary TB (1). It spreads through the air 
when diseased person coughs or sneezes (2). In 2014, 9.6 million 
new cases of TB were diagnosed and TB was a cause of death 
for 1.5 million patients worldwide (3). One-third of the world’s 
populations, that is, nearly 2.5 billion individuals are infected 
with MTb, but remain asymptomatic; among them, only 10% 
will develop clinically active TB in their lifetime (1). Though 
TB cases are declining due to effective antibiotic regiments, 
interest in TB has resurfaced due to the global emergence of 
multiple drug-resistant (MDR) and extreme drug-resistant 
(XDR) strains. As new resistant strains are making antibiotics 
obsolete, it has become pertinent to study the host–pathogen 
interaction to develop strategies which could augment host to 
fight against the pathogen. To achieve this, understanding of the 
host immune dynamics at its fundamental level is essential. The 
evolutionary arms race has endowed both the pathogen and host 
with several advantages to counter each other strategies. The 
fight between pathogen effectors and host immunity determines 
whether the pathogen is eliminated, made ineffective, or causes 
disease. When MTb is inside the human lung, phagocytic cells 
act as antigen-presenting cells (APCs) to neutralize the pathogen. 
APCs, such as neutrophils, dendritic cells, and macrophages, 
are known to concomitantly act to initiate T cell-based adaptive 
immunity to clear out the infection (4). Macrophages are of 
central importance as they possess a battery of immunological 
processes to kill the pathogen. Macrophages normally generate 
toxic nitrogen and oxygen radicals and induce autophagy and 
apoptosis to eliminate the pathogen. These capabilities are 
severely compromised by MTb and can, in turn, be manipulated 
for its survival. MTb has been experimentally shown to evade 
both apoptosis and autophagy by altering the intracellular 
machinery of the macrophage (5). In macrophage, a pathogen is 
normally phagocytosed and gets encased in endosome inside the 
cytosol. When this endosome matures, it fuses with the lysosome 
whereby the pathogen is neutralized, but MTb has the capacity to 
perturb the intracellular trafficking. It incapacitates phagosomal 
acidification by arresting its fusion with the lysosome (6). This 
crucial hindrance, which prevents phagolysosome maturation, 
leads to the survival of MTb inside the macrophage. This feat is 
achieved by MTb due to its interference with several intracel-
lular pathways. It inhibits Rab5-dependent endosome matura-
tion, modulates Ca2+ and PI3P-based signaling along with the 
modification of the actin cytoskeleton to prevent its fusion 
with the lysosome (7). By modulating intracellular mediators, 
MTb establishes an immunological block that leads to a chronic 
inflammatory condition in which it continues to persist. Host 
counteracts the onslaught and initiates an adaptive immune 
response by forming a granuloma, an immunological barricade 
to contain the further infection. By the time infection progresses, 
T-helper (TH1) cell with its cytokine secretions, such as tumor 
necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ), 
propagates the adaptive limb of the immunity (8). The granu-
loma is established when a sufficient inflammatory response is 
generated by TH1 cells along with the expression of inflamma-
tory chemokine (9). The main effector cells which are affected 
by cytokines of TH1 cells are macrophages. TH1 response primes 
macrophages by upregulating major histocompatibility complex 
(MHC)-2 and activating appropriate signaling pathways neces-
sary for the elimination of intracellular pathogens. MTb has the 
capacity to resist the deadly assault of the macrophage. Other 
than that, macrophages show a high level of plasticity and can 
differentiate into two opposite phenotypes (10). M1 macrophages 
are classically activated macrophages, which are immune-
stimulatory and are influenced by cytokines, such as IFN-γ and 
TNF-α. M2 cells are alternatively activated macrophages, which 
are characterized by their immuno-suppressive properties, such 
as enhanced IL4, IL10, and IL-13 response (11). There is a lot 
of ambiguity in M1/M2 nomenclature, but certain transcription 
factors and cytokines have been shown to differentiate these 
extreme phenotypes (Figure 1).
Apart from M1/M2 plasticity, macrophages can also trans-
form into foam cells, which are rich in lipid and cholesterol (12). 
Foamy macrophages are cells with deregulated lipid metabolism 
(13, 14). The homeostatic balance between the influx and 
efflux of low-density lipoprotein (LDL) comprising cholesterol, 
triacylglycerides, and phospholipids, is compromised in these 
cells. This modification is achieved in two steps, first, scavenger 
receptors and CD36, leads to increased uptake of LDLs by the 
macrophages. Second, transporters like ABCA1 that regulate the 
efflux of excess cholesterol are affected inside these macrophages. 
ABCA1 knockdown has been associated with exacerbated 
conditions of foam cells. Increased uptake of LDLs and later its 
compromised efflux suits the nutritional requirement of MTb 
(13). MTb has also been shown to modulate the ketone body 
synthesis to accumulate lipid bodies inside the macrophages 
(14). Peroxisome proliferator-activated receptor (PPAR) group 
of transcription factors have also been implicated in both M2 
transition and later in foam cell formation. PPARs upregulate 
metabolism genes and also represses M1 phenotypic marker 
(15). All of these factors are susceptible to modulation by MTb 
for its survival. These modified macrophages in the form of 
foamy cells are shown to be a predominant niche for MTb in 
granuloma (16) (Figure 1).
In TB, granuloma formation is an immunologically dynamic 
process which involves both innate and adaptive mechanisms. 
Few studies have focused on M1 and M2 macrophages bias in 
granuloma (17). The confirmed presence of M1, M2, and foamy 
macrophages in granuloma warrants further investigations 
to understand its transition and its role in the pathology of 
the disease. We have suspected the role of microRNAs against 
some transcription factors which transcribe critical genes that 
affect the M1/M2/Foamy macrophage continuum. miRNAs are 
evolutionarily conserved, 20–24 nucleotide small non-coding 
RNA, which inhibits the expression of genes by binding to the 
3′-UTR of the transcribed mRNAs. The recognition of mRNA 
nucleotides by 6–8 nucleotides long seed region of miRNA is suf-
ficient to inhibit the gene expression (18). The miRNA–mRNA 
FigUre 1 | microrna overlapping M2 and foam cell formation promotes Mycobacterium tuberculosis survival.
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complex leads to mRNA destabilization, translational inhibition, 
or mRNA degradation. miRNA has been shown to play diverse 
roles from affecting developmental pathways to immunological 
mechanisms (19). The specific variations in miRNA expression 
during immune cell development are increasingly being appreci-
ated. Its aberrant expression has been linked to infections, aging, 
and other pathological outcomes (20). As monocyte transition to 
macrophage is a continuous process, the perturbed expression of 
miRNA can influence its phenotype under certain temporal and 
spatial conditions. In this study, we have identified transcription 
factors which can regulate macrophage polarization during MTb 
infection. In fact, several studies have corroborated that levels of 
transcription factors present in cytosol influence the gene expres-
sion profile of a particular cell (21, 22). MTb-associated miRNA 
modulation can lead to a quantitative variation of transcription 
factors inside the macrophage either by directly altering the 
transcription factor or by influencing other proteins interacting 
with the transcription factors. There has been evidence that PtpA 
secreted by MTb directly dephosphorylates p-Jnk and p-p38, thus 
modulating cytokine expression (23).
In this computational study, we have identified key miRNAs 
that can be upregulated or repressed to skew the macrophage 
polarity to pro-survival M2 phenotype. Transcription factors 
like IRF5, IRF1, SOCS1, STAT1, and STAT2 promotes inflam-
matory M1 macrophage, and its MTb-based suppression 
enhances its survival. Transcription factors expressed by M2 
macrophages, such as IRF4, SP1, SP3, STAT6, SOCS 2, SOCS 3, 
PPAR, and KLF6, were also analyzed in this study. Their upregu-
lation boosts the survival of MTb (Figure 1). This study revealed 
novel MTb-associated miRNAs which bind to the 3′-UTR of 
the aforesaid transcription factors. The variation in the miRNA 
profile decides the fate of the macrophage to which survival of 
MTb is intertwined. Later, we analyzed few microRNAs which 
fulfills the dual role of transition from M2 phenotype to nutri-
tional rich foam cells. Similar computational approaches have 
been used in deciphering the role of miRNAs in other human 
disorders (24, 25).
MaTerials anD MeThODOlOgY
identification of Target Transcription 
Factors
MTb survival is greatly enhanced when macrophage polar-
ity is shifted toward M2 macrophage. We have identified key 
transcriptional factors from the published literature that were 
experimentally shown to affect macrophage polarization state 
and are listed in Table 1.
resources Used for mirna Prediction
We have used five freely accessible databases which are avail-
able online to predict potential miRNAs against target genes 
(Table 2). For this study, first, we submitted target gene ID into 
TargetScan database to identify matching conserved miRNA 
sequences. TargetScan returned queries in two sets, first set, 
conserved sequences with a high probability of binding between 
seed region of mRNA and second set comprised of poorly con-
served miRNA. The algorithm threshold was set automatically 
according to the length of the seed sequence. In all the resulting 
hits of the miRNAs, the length of the seed sequence matching 
the mature mRNA was ≥7mers. The context ++ percentile score 
was used to curate results on the basis of a statistical model to 
predict miRNA/mRNA interaction (34). Context ++ percentile 
score ranks microRNAs according to its efficacy of binding. Only 
TaBle 2 | list of online resources used for microrna prediction.
s. 
no.
Tool name Uniform resource locator reference
1 TargetScan http://www.TargetScan.org (34)
2 miRDB http://miRDB.org/miRDB (39)
3 miRANDA-
mirSVR
http://www.microrna.org (40)
4 DIANA-
microT
http://diana.imis.athena-innovation.gr/
DianaTools/index.php?r=microT_CDS/index
(35)
5 miRNAMap http://mirnamap.mbc.nctu.edu.tw (38)
TaBle 1 | Transcription factors and their functional aspects toward the plasticity of M1 or M2 phenotype.
s. 
no.
Type of 
phenotype
Transcription 
factors
Full name Function reference
1 M1 
phenotype
IRF5 Interferon regulatory factor 5 Required for MyD88 signaling and drives pro inflammatory 
response
(26)
2 IRF1 Interferon regulatory factor 1 Interacts with Myd88 and activates pro-inflammatory genes (27)
3 SOCS 1 Suppressor of cytokine signaling 1 High SOCS 1/SOCS 3 ratio drives toward M1 (28)
4 STAT1 Signal transducer and activator of transcription 1 Required for interferon-gamma-based pro-inflammatory 
genes activation
(29)
5 STAT2 Signal transducer and activator of transcription 1 Forms heterodimer with STAT1 (29)
6 M2 
phenotype
IRF4 Interferon regulatory factor 4 Promotes M2 (29)
7 SP1 Specificity protein 1 Transcription factor for IL-10 gene (30)
8 SP3 Specificity protein 3 Transcription factor for IL-10 gene (30)
9 PPAR-δ Peroxisome proliferator-activated receptor delta Promotes anti-inflammatory M2 phenotype (31)
10 PPAR-α Peroxisome proliferator-activated receptor alpha Promotes M2 (32)
11 PPAR-γ Peroxisome proliferator-activated receptor gamma Leads in fatty acid metabolism and sustains M2 phenotype (15)
12 SOCS2 Suppressor of cytokine signaling 2 Highs SOCS 2 leads to M2 (28)
13 SOCS 3 Suppressor of cytokine signaling 3 High SOCS 3/SOCS 1 ratio drives toward M2 (28)
14 STAT6 Signal transducer and activator of transcription 6 Induces M2 specific genes (29)
15 KLF4 Kruppel-like factor 4 Inhibits M1 promotes M2 (33)
4
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conserved hits (with context ++ score ≥90%) were filtered and 
authenticated in other databases. Other four web servers used 
in this study were: DIANA-microT, which identifies miRNA 
recognition elements by comparing given miRNA with mock 
miRNA sequence (35), miRDB utilizes support vector machines 
for target prediction (36), miRanda-mirSVR is an online miRNA 
analysis tool which utilizes a new machine learning method 
which is trained on in vitro miRNA transfection experiments on 
HeLa cells (37), and miRNAMap primarily considers Gibbs free 
energy and miRanda score to predict target sites (38).
resUlTs
The MTb-Dependent Downregulation of 
M1 Phenotypic Properties
Macrophage polarization leads to two states, one is a pro-
inflammatory M1 state, which encompasses IFN-γ-mediated 
response and microbicidal action. The second state is an M2 state, 
which is an anti-inflammatory state pre-dominated by IL4- and 
IL10-mediated cell profile. MTb-dependent perturbations in 
the host’s microRNA profile would enhance its survival only if 
it could negate the host’s lethal response. To identify microRNAs 
against transcription factors required for M1 cell, we submitted 
IRF5 (GENE ID 3663) for miRNA search in TargetScan database. 
The data search revealed that miR-302c and miR-520b were 
conserved with the high context ++ score. But only miR-302c, 
which targets 3′-UTR position at 452–459 of IRF5, was validated 
on miRanda-mirSVR and miRDB databases (Table 3).
IRF1 has been associated with M1 macrophages. IRF1 interacts 
with Myd88 and activates inflammatory genes. miR-454, miR-
130a, and mir-130b have binding affinity for 3′-UTR position at 
394–401 of IRF1. Its downregulation will prevent M1-specific 
response (Table 3).
The STAT family of transcription factors plays a differential 
role in the outcome of macrophage. miR-1252 and miR-3202 
showed complementarity for STAT1 and STAT2, respectively in 
≥2 databases. Downregulation of these transcription factors will 
lead to a reduced inflammatory response (Table 3).
Suppressor of cytokine signaling (SOCS) affects signaling 
cascade influencing M1 and M2 outcome. SOCS 3 is an essential 
transcription factor for M1 macrophage conversion. The miR-
455-5p was found to possess an affinity for position 1564–1570 
of 3′-UTR of SOCS3. The miR-455-5p target site was confirmed 
in four databases except for miRNAMap. The expression of miR-
455-3p will downregulate SOCS 3 expression which is essential 
for M1 phenotype, thus promoting M2 phenotype (Table  3; 
Figure 2).
MTb-Dependent Macrophage imbalance 
toward M2 Phenotype
IRF4 is an essential transcription factor for M2 phenotype 
generation but is dispensable for M1 development. Two micro-
RNAs, miR-27a and miR-27b, showed conserved binding to 
position 437–444 of IRF4 3′-UTR with high PCT (Probability of 
Conservation) and context ++ percentile score. The binding of 
these miRNAs was corroborated on miRanda-mirSVR, miRDB, 
and microT databases. Among the STAT family of transducers, 
STAT6 has been positively associated with an M2 cell type. 
TargetScan, miRDB, and miRanda-mirSVR revealed putative 
binding sites for miR-135a-5p and miR-135b-5p at position 
TaBle 3 | Predicted microrna against different transcription factors playing role in M1/M2 plastcity.
s. no. Transcription factors Targetscan miranda–mirsVr mirDB microT mirnaMap
1 IRF5 miR-302c
miR-520b
miR-302c
miR-520b
miR-302c
–
–
–
–
–
2 IRF1 miR-454
miR-130a
miR-130b
miR-454
miR-130a
miR-130b
miR-454
miR-130a
miR-130b
miR-454
miR-130a
miR-130b
–
–
–
3 SOCS 1 miR-155
–
miR-155
miR-7c
–
miR-7c
miR-155
–
miR-155
–
4 STAT1 – – miR-1252-5p miR-1252 –
5 STAT2 miR-3202 – miR-3202 miR-3202 –
6 IRF4 miR-27a
miR-27b
miR-27a
miR-27b
miR-27a
miR-27b
miR-27a
miR-27b
–
–
7 SP1 miR-135a-5p
miR-135b-5p
miR-135a-5p
miR-135b-5p
miR-135a-5p 
miR-135b-5p
miR-135a-5p
–
–
–
8 SP3 miR-129-5p miR-129-5p miR-129-5p – –
9 SOCS2 miR-132
miR-212
–
–
–
–
miR-132
miR-212
miR-132
miR-212
10 SOCS 3 miR-455-5p miR-455-5p miR-455-5p miR-455 –
11 KLF4 miR-34c
miR-449
miR-34c
miR-449
miR-34c
miR-449
miR-449
–
miR-34c
miR-449
12 STAT6 miR-135a-5p
miR-135b-5p
miR-135a
miR-135b
miR-135a-5p
miR-135b-5p
–
–
–
–
13 Peroxisome proliferator-activated receptor (PPAR)-δ miR-138-5p miR-138 miR-138-5p miR-138-5p –
14 PPAR-γ miR-454 
miR-301a
miR-454 
miR-301a
miR-454 
miR-301a
–
–
miR-454
–
15 PPAR-α miR-19a
miR-19b
–
–
miR-19a
miR-19b
–
–
miR-19a
miR-19b
5
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1100–1107 of STAT6. These microRNA when upregulated, would 
promote M2 phenotype (Table 3).
High SOCS1 to SOCS3 ratio affects signaling cascade dif-
ferentially by promoting M2 macrophage. When submitted in 
TargetScan, miR-155-5p binds at position 24–31 of SOCS1 3′-
UTR. Its affinity was confirmed on miRanda-mirSVR, microT, 
and microRNAMap. Conserved microRNAs predicted on 
TargetScan for SOCS2 3′-UTR at position 1535–1542 was miR-132 
and miR-212. Its affinity was simultaneously confirmed through 
TargetScan, microT, and miRNAMap databases (Table 3).
SP1 and SP3 are known to transcriptionally upregulate IL-10 
gene. TargetScan output has shown that SP1 has a conserved 
target at 344–350 nucleotide position of 3′-UTR for miR-135a-5p 
and 135b. The validation of miR-135a-5p was confirmed in all the 
four databases except miRNAMap. For SP2, miR-129-5p at 93-99 
position of 3′-UTR was confirmed in TargetScan, miRanda-
mirSVR, and miRDB. Downregulation of microRNAs against 
SP1 and SP2 leads to upregulation of IL10 expression, in turn, 
promoting M2 phenotype (Table 3).
High activity of KLF4 is associated with M2 macrophages 
but is significantly reduced in M1. Its 3′-UTR sequence at 25–32 
nucleotides shows conserved targets for miR-449b-5p and miR-
34c-5p (Table 3; Figure 2).
microRNA have been also implicated in lipid metabolism and 
can potentially assist in the transition of M2 cell to foamy mac-
rophage. Our data-mining in multiple databases confirmed that 
miR-155 has the conserved binding site against ABCA1. miR-33 
which play a role in lipid deregulation binds to the 3′-UTR of 
NOD2. Another critical microRNA, miR-27a/b has a putative 
binding site at 3′-UTR of IRF4.
Among all the 15 transcription factors analyzed, 1 had hit in 
all five databases, 7 microRNAs were positively authenticated 
on four databases and 6 had hits in three databases. Except for 
one gene all the microRNAs were validated in ≥3 databases with 
different algorithms.
DiscUssiOn
Tuberculosis involves combined effort of innate and adaptive 
immunity to clear out the infection. Macrophages are the central 
immune cells, as they possess an arsenal of toxic mechanisms 
sufficient to kill the pathogen. MTb-dependent modulation of 
macrophage, whereby it not only survives but also thrives, is 
one of the great evolutionary adaptations. In the host, mac-
rophages’ plasticity yields predominantly pro-inflammatory 
M1 macrophages and anti-inflammatory M2 macrophages. 
FigUre 2 | microrna promoting M2 phenotype for Mycobacterium 
tuberculosis survival.
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For MTb, the advantage of M2 cells could be gauged by the 
fact that it downregulates the antigen presentation molecules 
and co-stimulatory receptors, in turn impairing the activation 
of TH1 cells (41). The absence of TH1 response coupled with 
immune manipulation to generate M2 creates a comfortable 
niche for this pathogen. Add to it, the capacity to transform 
macrophage into a foam cell, MTb successfully manipulates the 
host to generate a safe harbor for its long-term survival (16). 
The crucial molecular factors which are essential for deciding 
the phenotypic outcome of a macrophage is of great interest 
as the survival of pathogens is dictated by the lethality of 
macrophage response. As infection by MTb progresses, the 
defensive action of host creates an immunological barricade 
called a granuloma. There has been evidence suggesting the 
presence of both types of macrophages in the granuloma (17). 
During the initial stages of infection, M1 type of macrophages 
predominates, but loses out to M2 as the infection progresses 
(17). M1/M2 polarization is based on the differential expression 
of genes in a macrophage. For example, IL-23- and IL-12-
secreting M1 macrophages promote mycobacterial killing, 
but IL-10-secreting M2 expression subverts its killing (41). 
Expression of these genes is controlled by specific transcription 
factors, which express a single gene or a set of genes (42). The 
fine-tuning of gene expression with respect to transcription 
factors could be achieved in two ways. First, the downregulation 
or upregulation of the transcription factors in the cell leads to 
the corresponding effect on the quantity of the gene product. 
Second, modification of transcription factor also influences the 
gene expression. Certain transcription factor such as NFAT 
must be dephosphorylated before they can translocate to the 
nucleus (43). Some studies have shown that the quantity of 
transcription factor as a key variable in deciding the inflam-
matory status of the macrophage (21, 22). We have pointed 
out that MTb-dependent miRNAs modulation of transcription 
factors might be one of the molecular factors that have the 
capacity to tip the balance toward pro-survival M2 phenotype.
In this computational study, we have uncovered few critical 
transcription factors which influence the M1/M2 plasticity and 
are potential targets modulated by MTb. Indeed, many other stud-
ies are also pointing at the role of microRNAs in various immune 
cells, including macrophages (20). Experimentally several studies 
have documented MTb-dependent miRNA modulation (44, 45). 
The pathogen downregulates inflammatory molecules IFN-γ, 
TNF-α, and IRAK1 by modulating several miRNAs (46–48). 
In this study, by analyzing multiple databases, we have filtered 
critical micro RNAs that can affect the availability of TFs. Initial 
hits were selected from TargetScan as it uses PCT and context ++ 
percentile score. Higher score translates to a better probability 
of binding with the given mRNA. These filtered miRNAs were 
further analyzed by other databases.
The interferon regulatory elements (IRF) are transcription 
factors which upregulate the transcription of a specific set of 
genes and play a significant role in deciding the outcome of 
macrophage phenotype. For M1 macrophage, IRF5 is the critical 
transcription factor which influences the inflammatory response 
of the macrophage (26). IRF5 depended production of IL-12 
by M1 macrophage is required to IFN-γ-dependent pathway in 
TH1 cells. IFN-γ then potentiates the macrophages to unleash its 
antibacterial arsenal (49). IRF5 also inhibits the transcription of 
IL10, thus negatively regulates M2 phenotype. Its upregulation 
is synonymous with M1 and down regulation leads to M2 cells. 
IRF1 also plays its part by inducing Myd88-dependent pathway, 
but recent evidence has also suggested its association with BATF1 
which leads to the expression of several host protective genes 
against MTb (50). Its knockdown lead to severe downregulation 
of IFN-γ-dependent pro-inflammatory limb (50). IRF5 and IRF1 
down-modulation by miRNAs prolong the survival of MTb in 
macrophages.
IRF4, another transcription factor is essential for generating 
M2 phenotype. IRF 4 is known to associate with Jmjd3, an H3K27 
demethylase, and has been implicated in the promotion of M2 
phenotype (51). We found out that miR-302c putatively controls 
IRF5 expression, and miR-27a and miR-27b regulate IRF4 
expression. For the promotion of M2 macrophage, it is essential 
to downregulate IRF5 by upregulating miR-302c. Expression of 
IRF4 can be affected by downregulating miR-27a and miR-27b. 
When perturbed by MTb, these miRNA can significantly alter the 
macrophage polarization status, thus providing a means to MTb 
for its survival.
STATs are an intracellular transducer that regulates the expres-
sion of several immune genes in macrophages. These participate 
by expressing higher MHC-2, IL-12, and Nitric oxide synthase 
(NOS), necessary for killing of the pathogen (52). STAT1 and 
STAT2, transducers play their part in M1 polarization, they form 
7Ahluwalia et al. microRNA-Mediated Immunological Plasticity
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a heterodimer to induce transcription of several microbicidal 
genes. miR-1252 and miR-3202 against STAT1 and STAT2 will 
downregulate M1-specific response.
Suppressor of cytokine signaling proteins has been shown to 
play a key role in M1 and M2 macrophage polarization. Expression 
of SOCS is highly context dependent and is actively triggered 
once the macrophage is activated. SOCS plays a dampening 
effect on JAK/STAT signaling pathways through its association 
with phosphorylated tyrosine. SOCS also utilizes proteasome 
machinery to degrade signaling molecules. High SOCS1 and 
SOCS2 have been associated with M2 polarization, and high 
SOCS3 promotes M1 phenotype (53, 54). Downregulation of 
miR-155-5p against SOCS1 will result in corresponding increase 
in SOCS1. The down-modulation of miR-132 will increase 
SOCS2. High SOCS1 and SOCS2 will promote pro-survival M2 
phenotype. At the same time, MTb has the capacity to increase 
miR-455 expression which possesses conserved complementa-
rity against SOCS3 and thus, prevents the cell from generating 
M1-specific response.
As IFN-γ and TNF-α are associated with M1 macrophages, 
IL-4 and IL-10 are known to be associated with M2 macrophages 
(10). SP1 and STAT6 both play an important role in the outcome 
of the M2 phenotype. STAT6 plays its part in IL-4-dependent 
cell signaling (55). SP1 has been shown to bind to IL10 motif, 
thus regulating its expression which is critical for M2 cell (30). 
IL-10 promotes anti-inflammatory genes and is associated with 
a dampening of the immune response. Our computation study 
predicted the affinity of miR-135a and miR-135b to these mRNA. 
MTb-dependent downregulation of this microRNA will be 
advantageous to MTb as it greatly enhances the formation of M2 
phenotype.
KLF4 is also essential for M2 as it is highly expressed in M2 
macrophages but is significantly reduced in M1 macrophages 
(33). It binds to STAT6 and sequesters co-activators required for 
NF-κB. As it is an important transcription factor which expresses 
an inflammatory gene, its unavailability shifts the macrophage 
toward M2 path. Our study found that miR-34c and miR-449 
have conserved targets against KLF4. MTb-dependent upregula-
tion of KLF4 through negative modulation by these microRNAs 
might lead to M2 phenotype.
Modulation of Transcription Factors for 
Foam cells in the granuloma
Foam cells are lipid-rich macrophages and are abundantly 
present in the granuloma (12). These are nutritionally rich cells 
where phagocytic and bactericidal activities are permanently 
compromised (16). MTb has remarkably long survival time in 
foam cells. It is a nutritionally rich microenvironment for MTb. 
In this safe haven, MTb can enter dormancy and can actively 
reproduce when suitable conditions emerge (56). Molecular fac-
tors affecting foam cell formation are of critical interest. PPARs 
are nuclear receptors, which act as transcription factors for genes 
playing an essential role in cellular metabolism, predominantly, 
glucose and lipid metabolism. Apart from this function, PPAR-α, 
-δ, -γ has shown the capacity to influence macrophage plasticity. 
They actively promote M2 phenotype by repressing inflamma-
tory genes through interference with the pro-inflammatory 
transcription factors, such as NF-κB (15). Development of 
human monocyte is skewed toward anti-inflammatory M2 when 
in presence of PPAR-γ. PPAR-γ activation correlates positively 
with M2 phenotypic markers. In one step ahead, PPAR-α and 
PPAR-γ have been implicated in ABCA1-mediated cholesterol 
efflux from macrophages (57). Thus, PPAR-mediated pathways 
play a role both in M2 macrophage generation and foam cell 
formation by regulating cholesterol efflux. MTb has been shown 
to depend on cholesterol metabolism for its long-term persis-
tence (58). Our data mining in multiple databases confirmed 
that miR-155 has the conserved binding site against ABCA1. By 
upregulating miR-155 late in infection, MTb has the capacity 
to block cholesterol efflux, by downregulating ABCA1, thus, 
securing its cholesterol requirements inside the foam cells. 
Experimental evidence has also suggested that miR-155 acts by 
directly repressing HBP1 expression, in turn, promoting lipid 
uptake (59). Interestingly, in TB patients, studies have shown 
increased expression of miR-155 (60, 61). By expressing miR-155, 
MTb can negate microbicidal cytokines and on the same hand 
prime foam cell formation. There is also a report which shows 
that mir-155 enhances autophagy (23) but autophagy itself is 
modulated in the presence of anti-inflammatory cytokines (62). 
miR-155 play role in suppressing inflammation and later lipid 
uptake creates ideal conditions for its survival and abrogates 
autophagy.
One of the transcription factors related to lipid metabolism 
is SREBP. It is required for upregulation of fatty acid and cho-
lesterol metabolism genes. SREBP1 and SREBP2 also express 
miR-33 which is present in its intronic region. miR-33 binds 
to ABCA1 and prevents the efflux of cholesterol from the cell 
(63, 64). Increased SREBP expression will not only extend 
lipolytic machinery but, through miR-33 expression, can also 
block cholesterol efflux, thus promoting foam cell formation. 
The modulation of miR-33 will again serve dual purposes for 
MTb by increasing fatty acid metabolism genes and at the same 
time reducing the outflow of cholesterol. Cholesterol and fatty 
acids are known to be nutrients for MTb, and its accumulation 
enhances its survival. Our database search also found that miR-33 
binds to 3′-UTR of NOD2. Downregulation of NOD2 dampens 
the inflammatory response (65). In fact, a recent study found 
out that MTb induced expression of miR-33 lead to deregulated 
autophagy, a protection strategy for the MTb. It also enhanced 
lipid catabolism which is essential for its nourishment (66). 
miR-27a/b has been experimentally shown to regulate choles-
terol homeostasis in THP1-macrophages (67). Our analysis has 
revealed that miR-27a/b has a putative binding site at 3′-UTR 
of IRF4. Pathogen-mediated modulation of this microRNA will 
subvert the immune response along with metabolic perturba-
tions required for its survival. Further experiments are required 
to fill the gaps in our current understanding of the microRNAs 
role in M1/M2 polarization and subsequently foam cell forma-
tion in granulomatous conditions.
Computational investigations have been conducted in cancer 
biology to identify critical microRNAs and their role in disease 
pathogenesis (25). The criteria followed in these studies are 
variable and at times is analyzed using a single database. In this 
study, the computational approach followed is highly stringent 
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and requires the hit to be identified and validated by ≥3 data-
bases. The hits in multiple databases are important as various 
databases use different algorithms and selection criterion to find 
microRNA/mRNA match, thus, strengthening its probability 
of function in  vivo. Using this approach, we have shown that 
multiple microRNAs can be modulated by MTb for its survival 
(Table  3). MTb has adapted to manipulate host metabolism 
and immune response at the same time by modulating its 
overlapping transcription factors. Experimental evidence must 
corroborate the role of microRNAs that are found in this in silico 
study. Further investigations should decipher novel miRNAs 
that influences TB pathogenesis. Future studies might document 
the use of microRNAs as novel therapeutic targets for curbing 
the spread of TB.
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